Results

Total Results: over 10,000 records

Showing results for "drugs".

9761. Basco, William | Digital Healthcare Research
      digital.ahrq.gov/principal-investigator/basco-william
      January 01, 2023 - Basco, William Assessment of Pediatric Look-Alike, Sound-Alike Substitution Errors - Final Report Citation Basco W. Assessment of Pediatric Look-Alike, Sound-Alike Substitution Errors - Final Report. (Prepared by the Medical University of South Carolina under Grant No. R03 HS0…

9762. Electronic Library | Agency for Healthcare Research and Quality
      www.ahrq.gov/policy/foia/foiaindx.html
      July 01, 2025 - Electronic Library The 1996 amendments to the Freedom of Information Act (FOIA) mandate that agencies must establish an Electronic FOIA (EFOIA) Library. The EFOIA Library contains certain agency manuals, specific agency policy statements, opinions made in adjudication of cases, and an index of records released …

9763. Weighted Summary Statistics: PUF Commercial Pharmacy File (Version 2) (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Commercial-Pharmacy-Weighted.pdf
      September 26, 2023 - Weighted Summary Statistics: PUF Commercial Pharmacy File (Version 2) 15:39 Tuesday, September 26, 2023 1 Weighted Summary Statistics: PUF Commercial Pharmacy File Variable Variable Label Count of Non-missing Values (Unweighted) Count of Missing Values (Unweighted) Minimum Maximum Mean Standard Deviation …

9764. Instructional Handouts for Staff and Patients | Agency for Healthcare Research and Quality
      www.ahrq.gov/hai/tools/abate/handouts.html
      May 01, 2022 - Instructional Handouts for Staff and Patients The Toolkit for Decolonization of non-ICU Patients With Devices provides several instructional handouts to train staff and teach patients about the decolonization protocol. Using staff handouts can ensure standardized and efficient training. Providing patients with …

9765. Psn-Pdf (pdf file)
      psnet.ahrq.gov/node/41816/psn-pdf
      September 26, 2016 - Designing for distractions: a human factors approach to decreasing interruptions at a centralised medication station. September 26, 2016 Colligan L, Guerlain S, Steck SE, et al. Designing for distractions: a human factors approach to decreasing interruptions at a centralised medication station. BMJ Qual Saf. 2012;…

9766. Psn-Pdf (pdf file)
      psnet.ahrq.gov/node/39489/psn-pdf
      June 11, 2010 - What happens between visits? Adverse and potential adverse events among a low-income, urban, ambulatory population with diabetes. June 11, 2010 Sarkar U, Handley MA, Gupta R, et al. What happens between visits? Adverse and potential adverse events among a low-income, urban, ambulatory population with diabetes. Qua…

9767. Psn-Pdf (pdf file)
      psnet.ahrq.gov/node/46923/psn-pdf
      August 17, 2018 - What can patients tell us about the quality and safety of hospital care? Findings from a UK multicentre survey study. August 17, 2018 O'Hara JK, Reynolds C, Moore S, et al. What can patients tell us about the quality and safety of hospital care? Findings from a UK multicentre survey study. BMJ Qual Saf. 2018;27(9)…

9768. CAHPS Cancer Care Supplemental Items (doc file)
      www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/suppl-items-cancer-access-english-557-1a.docx
      June 02, 2025 - CAHPS Cancer Care Supplemental Items CAHPS® Cancer Care Survey Supplemental Items: Access Population: Adult Supplemental Items for the CAHPS® Cancer Care Survey Topic: Access Population Version: Adult Language: English Users of the CAHPS® Cancer Care Survey are free to incorporate supplemental items in order t…

9769. AHRQ-Funded Patient Safety Project Highlights (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-hit-hie-rev-0724update.pdf
      July 01, 2024 - medication errors for three high-risk groups: patients with chronic kidney disease, people taking high-risk drugs

9770. Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting-future_research.pdf
      January 01, 2014 - Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs Future Research Needs Paper Number 25 Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs Future Research Nee…

9771. 2018 National Healthcare Quality and Disparities Report Data Sources (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2018qdr-datasources.pdf
      October 01, 2019 - are collected from medical records and include type of provider seen; reason for visit; diagnoses; drugs … characteristics; age at first use, lifetime, past-year, and past-month use of the following substances: illicit drugs

9772. In Conversation With… Urmimala Sarkar, MD, MPH | PSNet
      psnet.ahrq.gov/perspective/conversation-urmimala-sarkar-md-mph
      August 22, 2014 - In Conversation With… Urmimala Sarkar, MD, MPH August 1, 2014  Also Read an Essay Citation Text: In Conversation With… Urmimala Sarkar, MD, MPH. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Service…

9773. Microsoft Word - APS_DRG_Def_Public_V21.doc (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V21%20Weights%20Manual.pdf
      January 06, 2025 - Microsoft Word - APS_DRG_Def_Public_V21.doc APS-DRGs® NORMALIZED WEIGHTS – VERSION 21.0 TABLE OF CONTENTS All Payer Severity-adjusted DRGs (APS-DRGs®) Normalized Charge, LOS, and Mortality Weights Version 0402H (for APS-DRGs® Version 21.0) Copyrigh…

9774. Screening for Dyslipidemia in Younger Adults: A Systematic Review (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/SaASReVeD_fpHZQbeBZD5s
      October 01, 2016 - Screening for Dyslipidemia in Younger Adults: A Systematic Review Screening for Dyslipidemia in Younger Adults: A Systematic Review for the U.S. Preventive Services Task Force Roger Chou, MD; Tracy Dana, MLS; Ian Blazina, MPH; Monica Daeges, BA; Christina Bougatsos, MPH; and Thomas L. Jeanne, MD, MPH Background: Dys…

9775. Beyond the Hospital: the New Frontier of Patient Safety | PSNet
      psnet.ahrq.gov/perspective/beyond-hospital-new-frontier-patient-safety
      August 01, 2014 - Beyond the Hospital: the New Frontier of Patient Safety Margaret Plews-Ogan, MD, MS | August 22, 2014  Also Read a Conversation View more articles from the same authors. Citation Text: Plews-Ogan M. Beyond the Hospital: the New Frontier of Patient Safety. PSNet …

9776. Chipra-89-Adhd-Behavior-Section-5-Attach-5 (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
      February 02, 2012 - methylphenidate (Daytrana [Noven Therapeutics, LLC, Miami, FL]), or OROS methylphenidate (Concerta [Janssen Pharmaceuticals … COMMITTEE Mark Wolraich, MD, Chair – (periodic consultant to Shire, Eli Lilly, Shinogi, and Next Wave Pharmaceuticals … (neurologist; AAP Section on Neurology; Child Neurology Society) (Safety Monitoring Board for Best Pharmaceuticals … and other psychotic symptoms associated with the use of attention-deficit/hyper- activity disorder drugs … Cardiovascular monitor- ing and stimulant drugs for attention- deficit/hyperactivity disorder.

9777. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
      February 02, 2012 - methylphenidate (Daytrana [Noven Therapeutics, LLC, Miami, FL]), or OROS methylphenidate (Concerta [Janssen Pharmaceuticals … COMMITTEE Mark Wolraich, MD, Chair – (periodic consultant to Shire, Eli Lilly, Shinogi, and Next Wave Pharmaceuticals … neurologist; AAP Section on Neurology; Child Neurology Society) (Safety Monitoring Board for Best Pharmaceuticals … and other psychotic symptoms associated with the use of attention-deficit/hyper­ activity disorder drugs … Cardiovascular monitor­ ing and stimulant drugs for attention­ deficit/hyperactivity disorder.

9778. PS Grantee | Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/final-reports/index.html?page=7
      January 01, 2024 - Grantee Final Reports: Patient Safety Final reports from research grants administered since 2000 on a variety of patient safety topics, such as measure development, medication safety, and diagnostic safety. The Agency for Healthcare Research and Quality Center for Quality Improvement and Patient Safety subdivis…

9779. Behavioral Health Services Training | The Academy
      integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/obtain-training-and-support-providers-and-staff/behavioral-health-services-training
      June 01, 2022 - An official website of the Department of Health & Human Services Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates The Academy Integrating Behavioral Health & Primary Care Expand Navi…

9780. 4 Tk3 T1-Sample Policy Final (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/nhguide/4_TK3_T1-Sample_Policy_final.pdf
      October 01, 2016 - Nursing Home Antimicrobial Stewardship Guide Determine Whether To Treat Toolkit 3. Minimum Criteria for Common Infections Toolkit Tool 1. Sample Policy [NAME OF NURSING HOME] Protocol for Three Common Infections [DATE] Between 25 percent and 75 percent of antibiotic prescriptions in nursing homes do…